Back to Journals Drug Design, Development and Therapy Volume 20 Efimosfermin for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH): Mechanism of Action, Clinical Development and Emerging Therapeutic Potential Authors Alamgir M , Sohal A , Kowdley KV Received 6 January 2026 Accepted for publication 19 March 2026 Published 31 March 2026 Volume 2026:20 560039 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Anastasios Lymperopoulos Mariam Alamgir, 1 Aalam Sohal, 1, 2 Kris V Kowdley 1, 3 1 Department of Hepatology, Liver Institute Northwest, Seattle, WA, USA
Nevertheless, individual patient factorsincluding age, menopausal status, baseline bone health, and degree of weight losswarrant consideration in clinical practice
Real Weight Loss
If you are seeking IV drip therapy to brighten your skin tone, you can avail glutathione and vitamin-C infusions at Kosmoderma
What you might notice: slightly more stable energy after meals, fewer intense cravings in the evening, less of that desperate hunger that hits two hours after eating
Use it daily with sunscreen during the day for best results
